Search Results - "epstein-barr virus infections"

Epstein Barr Virus Quantitative Polymerase Chain Reaction Monitoring in Lung and Bone Marrow Transplant Patients to Predict Post-Transplant Lymphoproliferative Disorder: A Systematic Review.

Divithotawela C; Queensland Lung Transplant Program, The Prince Charles Hospital, Chermside, Queensland, Australia; The Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia. Electronic address: Chandima.Divithotawela@health.qld.gov.au., Lee SZ; Queensland Lung Transplant Program, The Prince Charles Hospital, Chermside, Queensland, Australia., Schulz M; Liverpool University Hospitals NHS FT, Liverpool, United Kingdom., Chambers DC; Queensland Lung Transplant Program, The Prince Charles Hospital, Chermside, Queensland, Australia; The Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.

Journal Article; Systematic Review; Review , 2025

DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report.

Nagata T; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Kubota H; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Kato I; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan. itarkt@kuhp.kyoto-u.ac.jp., Izawa K; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Akazawa R; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Jo T; Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Arai Y; Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Azumi S; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Kamitori T; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Saida S; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Umeda K; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Imadome KI; Department of Advanced Medicine for Infections, National Center for Child Health and Development (NCCHD), Tokyo, Japan., Yasumi T; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Hiramatsu H; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan., Takita J; Department of Pediatrics, Kyoto University Hospital, 54 Syogoin Kawaramachi Sakyo-Ku, Kyoto, 606-8507, Japan.

Journal Article; Case Reports , 2025

The regulatory effect and molecular mechanism of Epstein-Barr virus protein LMP-1 in SLE susceptibility gene expression.

Zhang X; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China.; Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Zhejiang-Macau International Joint Laboratory of Integrated Traditional Chinese and Western Medicine for Nephrology and Immunology, Hangzhou 310006, Zhejiang, PR China., Hu S; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China.; Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Zhejiang-Macau International Joint Laboratory of Integrated Traditional Chinese and Western Medicine for Nephrology and Immunology, Hangzhou 310006, Zhejiang, PR China., Luo P; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China., Li Z; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China.; Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Zhejiang-Macau International Joint Laboratory of Integrated Traditional Chinese and Western Medicine for Nephrology and Immunology, Hangzhou 310006, Zhejiang, PR China., Chen Z; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China.; Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Zhejiang-Macau International Joint Laboratory of Integrated Traditional Chinese and Western Medicine for Nephrology and Immunology, Hangzhou 310006, Zhejiang, PR China., Xia C; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China., Fan L; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China., Li R; Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang, PR China., Chen H; Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, PR China.; Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Zhejiang-Macau International Joint Laboratory of Integrated Traditional Chinese and Western Medicine for Nephrology and Immunology, Hangzhou 310006, Zhejiang, PR China.. Electronic address: chenhb521@126.com.

Journal Article , 2025

Characterizing resistant cellular states in nasopharyngeal carcinoma during EBV lytic induction.

Wang X; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China., Yu L; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China., Zhou X; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China., Chung GT; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Liu AM; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Chan YY; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Wu M; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Chau KY; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China., Lo KW; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China. kwlo@cuhk.edu.hk., Wu AR; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China. angelawu@ust.hk.; Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China. angelawu@ust.hk.; State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong SAR, China. angelawu@ust.hk.; Center for Aging Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China. angelawu@ust.hk.

Journal Article , 2025

Long-term survival analysis after radical gastrectomy for Epstein-Barr virus-associated gastric cancer: A multicenter study.

Xie RZ; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi Province, China., Huang ZN; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China., Zhang XQ; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China., Sun YQ; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Department of Gastrointestinal Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, China., Huang JB; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China., Chen QY; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China., Xie JW; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China., Zheng CH; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China., Huang CM; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China., Lin JX; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China., Li P; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, 350108 Fuzhou, Fujian Province, China. Electronic address: Pingli811002@163.com.

Journal Article; Multicenter Study , 2025

Incorporation of Epstein-Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma.

Kim IE Jr; Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA.; The Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA., Oduor C; Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA., Stamp J; Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA., Luftig MA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.; Center for Virology, Duke University School of Medicine, Durham, North Carolina, USA., Moormann AM; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Crawford L; Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA.; Microsoft Research, Cambridge, Massachusetts, USA., Bailey JA; Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA.; The Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA.

Journal Article , 2025

Posttransplant EBV-Positive Smooth Muscle Tumors in Children, Adolescents, and Young Adults: A Multi-Institution Experience.

Haney M; University of Cincinnati College of Medicine Department of Pediatrics, Cincinnati, Ohio, USA.; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, Ohio, USA., Devine KJ; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Xavier AC; Department of Pediatrics, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ford JB; University of Utah, Salt Lake City, Utah, USA.; Primary Children's Hospital, Salt Lake City, Utah, USA., Audino AN; Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA., Villagomez L; Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA., Kebede A; Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio, USA., Rubinstein JD; University of Cincinnati College of Medicine Department of Pediatrics, Cincinnati, Ohio, USA.; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, Ohio, USA.

Journal Article; Multicenter Study , 2025

Discovery of nuclear cavities in Epstein-Barr virus-infected cells.

Shimada S; Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: sshin-prm@m.u-tokyo.ac.jp., Kawasaki H; NanoSuit Research Laboratory, Institute of Photonics Medicine, Division of Preeminent Bioimaging Research, Hamamatsu University School of Medicine, Shizuoka, Japan., Katoh H; Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Ishikawa S; Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: ishum-prm@m.u-tokyo.ac.jp.

Journal Article , 2025

Clinical Outcome of UCBT for Children With CAEBV: A Retrospective Analysis of a Single Center.

Fu Z; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Li B; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Chai Y; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Guo X; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Chen X; Department of Pediatrics, Zhengzhou People's Hospital, Zhengzhou, China., Zhang L; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Chen J; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Wang D; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: deai315@163.com.

Journal Article , 2025

Development of a Diagnostic Algorithm for Epstein-Barr Virus-Related Diseases: A Retrospective Observational Study.

Li J; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Hou H; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Song J; Department of Gastroenterology & Endocrinology, Wuhan No. 9 Hospital, Wuhan, China., Yuan X; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Ma M; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Yang K; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wang P; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Guan Y; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Kuang D; Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Sun Z; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Meng F; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Peng J; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Cheng L; Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Journal Article; Observational Study; Multicenter Study , 2025

Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes.

Lledó-Delgado A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Preston-Hurlburt P; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Higdon L; Immune Tolerance Network, Bethesda, MD, 20814, USA., Hu A; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., James E; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., Lim N; Immune Tolerance Network, Bethesda, MD, 20814, USA., Long SA; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., McNamara J; Autoimmunity and Mucosal Immunology Branch, Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Nguyen H; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Serti E; Immune Tolerance Network, Bethesda, MD, 20814, USA., Sumida TS; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Herold KC; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. Kevan.herold@yale.edu.

Journal Article , 2025

Effects of venetoclax, a BCL2 inhibitor, in systemic chronic active Epstein-Barr virus disease.

Ohashi A; Department of Immunology and Parasitology, St. Marianna University School of Medicine, Kanagawa, Japan., Nishio M; Department of Hematology and Biophysical Systems Analysis, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan., Yoshimori M; Department of Hematology and Biophysical Systems Analysis, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.; Center of Blood Transfusion and Cell Therapy, Institute of Science Tokyo Hospital, Tokyo, Japan., Koike K; Department of Hematology and Biophysical Systems Analysis, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan., Kurata M; Division of Integrated Facilities, Pathology, Institute of Science Tokyo, Tokyo, Japan., Tamai H; Department of Hematology and Oncology, St. Marianna University School of Medicine, Kanagawa, Japan., Imadome KI; Department of Infectious diseases and Infection Control, Akiru Municipal Medical Center, Tokyo, Japan., Arai A; Department of Hematology and Biophysical Systems Analysis, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan. ara.hema@marianna-u.ac.jp.; Department of Hematology and Oncology, St. Marianna University School of Medicine, Kanagawa, Japan. ara.hema@marianna-u.ac.jp.

Journal Article , 2025

Long-term outcomes in patients with persistent EBV-DNA positivity after primary Epstein-Barr virus infection and clinical implications of rituximab therapy.

Liu M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China; Department of Hematology, Jingzhou Hospital, Affiliated to Yangtze University, China., Ma Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China., Hong Z; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China., Yin Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China., Gu J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China., Chen L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China., Zheng M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China. Electronic address: zmzk@sina.com.

Journal Article , 2025

Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.

Mawalla WF; Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Achola C; Oncology Unit, St Mary's Hospital Lacor, Gulu, Uganda., Nabalende H; Oncology Unit, St Mary's Hospital Lacor, Gulu, Uganda., Otim I; Oncology Unit, St Mary's Hospital Lacor, Gulu, Uganda., Legason ID; Oncology Unit, St Mary's Hospital Lacor, Gulu, Uganda., Ogwang MD; Oncology Unit, St Mary's Hospital Lacor, Gulu, Uganda., Aol PM; Oncology Unit, St Mary's Hospital Lacor, Gulu, Uganda., Sandi G; Paediatric Oncology Unit, Muhimbili National Hospital, Dar es Salaam, Tanzania., Mwamtemi H; Paediatric Oncology Unit, Muhimbili National Hospital, Dar es Salaam, Tanzania., Mahawi S; Paediatric Oncology Unit, Muhimbili National Hospital, Dar es Salaam, Tanzania., Mkwizu E; Cancer Care Centre, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Lyamuya PG; Cancer Care Centre, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Kamanga JP; Department of Oncology, Bugando Medical Centre, Mwanza, Tanzania., Schroeder K; Department of Oncology, Bugando Medical Centre, Mwanza, Tanzania., Ntemi P; Department of Oncology, Bugando Medical Centre, Mwanza, Tanzania., Chamba C; Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Vavoulis D; Department of Oncology, University of Oxford, Oxford, United Kingdom., Morrell L; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Chirande L; Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Schuh A; Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Department of Oncology, University of Oxford, Oxford, United Kingdom.

Journal Article; Observational Study , 2025

The lncRNA LINC02446 promotes tumor progression and HLH occurrence by regulating the expression of KLRs and IL-10 in EBV-NK-LPDs.

Ma Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China., Bao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China., Wang J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China., Yin Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China., Liu M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China., Hong Z; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China., Huang Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China., Zheng M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China. Electronic address: zmzk@sina.com.

Journal Article , 2025

Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells.

Cheng J; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Hu X; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.; Department of Hematology, The First Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, China., Dai Z; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Zeng Y; Department of Internal Medicine, Cleveland Clinic, Akron General, Cleveland, Ohio, USA.; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Jin J; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Mu W; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Wei Q; IASO Biotherapeutics, Nanjing, China., Jia X; IASO Biotherapeutics, Nanjing, China., Liu J; IASO Biotherapeutics, Nanjing, China., Xie M; IASO Biotherapeutics, Nanjing, China., Luo Q; IASO Biotherapeutics, Nanjing, China., Hu G; IASO Biotherapeutics, Nanjing, China., Wang G; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Wang J; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China., Tan T; IASO Biotherapeutics, Nanjing, China., Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.

Journal Article , 2025

Fatty acid desaturases link cell metabolism pathways to promote proliferation of Epstein-Barr virus-infected B cells.

Bonglack EN; Department of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, United States of America.; Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom., Hill KK; Department of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, United States of America., Barry AP; Department of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, United States of America., Bartlett A; Department of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, United States of America., Castellano-Escuder P; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, United States of America., Hirschey MD; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, United States of America., Luftig MA; Department of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, United States of America.

Journal Article , 2025

Epstein-Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways.

Delecluse S; Unit D400, DKFZ, Heidelberg, Germany.; Inserm joint unit, Heidelberg, Germany.; Department Nephrology, University of Heidelberg, Heidelberg, Germany.; German Center for Infection Research (DZIF), Braunschweig, Germany., Baccianti F; Unit D400, DKFZ, Heidelberg, Germany.; Inserm joint unit, Heidelberg, Germany., Zala M; Centre International de Recherche en Infectiologie (Team LIB), Université Lyon, INSERM, U1111, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, UMR5308, ENS de Lyon, Lyon, France.; Faculté de Médecine Lyon-Sud, Université de Lyon, Oullins, France., Steffens A; Unit D400, DKFZ, Heidelberg, Germany.; Inserm joint unit, Heidelberg, Germany.; University of Heidelberg, Heidelberg, Germany., Drenda C; Biostatistics Unit C60, DKFZ, Heidelberg, Germany., Judt D; Unit D400, DKFZ, Heidelberg, Germany.; Inserm joint unit, Heidelberg, Germany., Holland-Letz T; Biostatistics Unit C60, DKFZ, Heidelberg, Germany., Poirey R; Unit D400, DKFZ, Heidelberg, Germany.; Inserm joint unit, Heidelberg, Germany., Sujobert P; Centre International de Recherche en Infectiologie (Team LIB), Université Lyon, INSERM, U1111, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, UMR5308, ENS de Lyon, Lyon, France.; Faculté de Médecine Lyon-Sud, Université de Lyon, Oullins, France., Delecluse HJ; Unit D400, DKFZ, Heidelberg, Germany. h.delecluse@dkfz.de.; Inserm joint unit, Heidelberg, Germany. h.delecluse@dkfz.de.

Journal Article , 2025

Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report.

Halabitska I; Department of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, Voli Square, 1, 46001 Ternopil, Ukraine., Petakh P; Department of Biochemistry and Pharmacology, Uzhhorod National University, 88000 Uzhhorod, Ukraine., Oksenych V; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway., Kamyshnyi O; Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine.

Case Reports; Journal Article , 2025

Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas.

Hai L; Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Friedel D; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Department of Neuropathology, Heidelberg University Hospital, and Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Hinz F; Department of Neuropathology, Heidelberg University Hospital, and Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Hoffmann DC; Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Doubrovinskaia S; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Rohdjess H; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Weidenauer K; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Denisova E; Division of Applied Bioinformatics, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Scheffler GT; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA., Kessler T; Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Kourtesakis A; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Herold-Mende C; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Henegariu O; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA., Baehring JM; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA., Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Brors B; Division of Applied Bioinformatics, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Wick W; Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Sahm F; Department of Neuropathology, Heidelberg University Hospital, and Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Kaulen LD; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.

Journal Article , 2025